Back | Next |
home / stock / bdsi / bdsi message board
Subject | By | Source | When |
---|---|---|---|
I thought the same about the Belbuca sales- | stock_clerk | investorshub | 08/12/2017 7:14:20 PM |
I sold 1/2 my position when it took | UFO | investorshub | 08/12/2017 6:09:23 PM |
A bit upset that $BDSI didn't hold that | stock_clerk | investorshub | 08/12/2017 5:00:50 PM |
Long $BDSI from today. Liked the price | UFO | investorshub | 07/24/2017 5:01:21 PM |
Fk That ! | DeafTrader2 | investorshub | 07/12/2017 1:46:16 PM |
$BDSI ....oversold yes but should we bet | DeafTrader2 | investorshub | 06/23/2017 3:12:54 PM |
$BDSI will it stay upward after two major | DeafTrader2 | investorshub | 06/23/2017 3:08:14 PM |
PoemStone: $BDSI flag formation $2.30 | PoemStone | investorshangout | 06/21/2017 10:09:11 PM |
About to cross $2.50 | RyGuy | investorshub | 05/19/2017 2:45:44 PM |
More importantly, Belbuca is what's going to turn | Jabroni123 | investorshub | 05/18/2017 9:33:03 PM |
* * $BDSI Video Chart 05-18-17 * * | ClayTrader | investorshub | 05/18/2017 9:05:43 PM |
$BDSI looking really good lately. Looks to be | RyGuy | investorshub | 05/18/2017 8:07:50 PM |
Nice news... | Obelax | investorshub | 05/15/2017 8:13:48 PM |
Looks like $BDSI about to start making a | RyGuy | investorshub | 05/12/2017 5:38:32 PM |
FDA approved nearly a triple quantity of prescriptions | RyGuy | investorshub | 05/11/2017 1:17:28 PM |
The FDA extended the use of Bunavwell for | bbhuey | investorshub | 05/02/2017 11:08:36 PM |
Gap n trp looks like :/ | stock1ace1 | investorshub | 05/02/2017 12:35:34 PM |
Nice news... | Obelax | investorshub | 05/02/2017 11:40:33 AM |
News. | Lone Wolf | investorshub | 05/02/2017 11:16:24 AM |
just sold for a couple od dollars profit. | T695 | investorshub | 04/05/2017 1:51:28 PM |
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...